Reaction
Haematological Malignancy reporting signals
As of the last recalculation, Haematological Malignancy appears in 2,798 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is RANITIDINE (PRR 34.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranitidine | 705 | 34.9 | 35.0 |
| Romiplostim | 52 | 26.2 | 26.2 |
| Ranitidine Hydrochloride | 153 | 22.1 | 22.2 |
| Eltrombopag Olamine | 34 | 11.1 | 11.1 |
| Fludarabine Phosphate | 57 | 11.0 | 11.0 |
| Thiotepa | 11 | 8.6 | 8.6 |
| Busulfan | 18 | 8.6 | 8.6 |
| Rucaparib | 7 | 5.9 | 5.9 |
| Melphalan Hydrochloride | 19 | 5.7 | 5.7 |
| Acalabrutinib | 7 | 4.3 | 4.3 |
| Anakinra | 9 | 4.0 | 4.0 |
| Thalidomide | 17 | 3.5 | 3.5 |
| Ruxolitinib | 27 | 2.8 | 2.8 |
| Polatuzumab Vedotin | 3 | 2.3 | 2.3 |
| Olaparib | 5 | 1.8 | 1.8 |